Medical Innovation Exchange

FDA sparks hope for Curis, lets biotech resume enrollment for part of phase 1/2 leukemia study

https://www.fiercebiotech.com/biotech/fda-sparks-hope-curis-lets-biotech-resume-enrollment-part-phase-12-leukemia-study

Leave a Comment

Your email address will not be published.

Leave the field below empty!